AI-powered disease progression prediction in multiple sclerosis using magnetic resonance imaging: a systematic review and meta-analysis

MRI-driven AI models predict MS disability progression with moderate accuracy, but error margins that exceed one EDSS point limit individual-level utility. Harmonized endpoints, larger multicenter cohorts, rigorous external validation, and prospective clinician-in-the-loop trials are essential before routine clinical adoption.